JPRN-UMIN000004746已完成未知
Effect of a DPP-4 inhibitor on vascular endothelial function in type 2 diabetic patients - Effect of a DPP-4 inhibitor on vascular endothelial function
ippon Medical School Department of Medicine Division of Cardiology, Hepatology,Geriatrics and Integrated Medicine0 个研究点目标入组 50 人开始时间: 2010年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with contraindications to sitagliptin use 2) The patient under insulin treatment 3) The patient under alpha-GI or Gulinide treatment 4) Women who are pregnant, possibly pregnant, or are breastfeeding 5) Patients who are determined by the lead principal investigator or contributing investigators to be unsuitable
研究者
相似试验
已完成
不适用
The effects of DPP-4 inhibitor on vascular endothelial function in patients with type 2 diabetes mellitusJPRN-UMIN000010016ippon Medical School Department of Medicine Division of Cardiology40
已完成
不适用
The effects of a DPP4 inhibitor on endothelial function in diabetic patients with coronary artery diseaseJPRN-UMIN000008806Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University30
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128
已完成
不适用
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitusPatients with type 2 diabetes mellitus who were suspected as having ischemic heart diseaseJPRN-UMIN000015381Kanagawa PTCA Conference50
尚未招募
不适用
The inhibitory effects of the DPP-4 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.The CKD patients with type 2 diabetesJPRN-UMIN000011101Saitama Medical Center, Saitama Medical University50